Filing Details
- Accession Number:
- 0001437749-18-019720
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-06 21:40:45
- Reporting Period:
- 2018-11-02
- Accepted Time:
- 2018-11-06 21:40:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 925741 | Biocardia Inc. | BCDA | Biological Products, (No Disgnostic Substances) (2836) | 232753988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647542 | Peter Altman | C/O Biocardia, Inc. 125 Shoreway Road, Suite B San Carlos CA 94070 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-02 | 400 | $2.52 | 718,992 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $2.44 to $2.60 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
